Literature DB >> 14606063

Correlation between expression of human telomerase subunits and telomerase activity in esophageal squamous cell carcinoma.

Chun Li1, Ming-Yao Wu, Ying-Rui Liang, Xian-Ying Wu.   

Abstract

AIM: To investigate telomerase activity and hTERT, TP-1 expression and their relationships in esophageal squamous cell carcinoma (ESCC).
METHODS: Telomerase activity was measured in 60 ESCC tissues using telomeric repeat amplification protocol (TRAP) assay by silver staining. In situ hybridization was used for detecting hTERT and TP-1mRNA.
RESULTS: The telomerase activity was detected in 83.3% of ESCC tissues. The difference of telomerase activity was significant between well and poorly cancer differentiated lesions (P<0.05). The positive rate of telomerase activity was higher in patients with lymphatic metastasis than in patients without lymphatic metastasis. In cancer tissues hTERT mRNA expression was 75% and TP-1 mRNA expression was 71.7%. The expression of hTERT, TP-1 mRNA in well and poorly differentiated carcinoma was not significant. The expression of hTERT mRNA was correlated with telomerase activity, but TP-1 mRNA expression was not correlated with it.
CONCLUSION: Telomerase activity and hTERT, TP-1 mRNA expression are up-regulated in ESCC. Telomerase activity in ESCC is correlated with lymphatic metastasis and cancer differentiation. Telomerase activity may be used as a prognostic marker in ESCC. hTERT mRNA expression is correlated with telomerase activity. Enhanced hTERT mRNA expression may initially comprehend the telomerase activity level, but it is less sensitive than TRAP assay.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14606063      PMCID: PMC4656508          DOI: 10.3748/wjg.v9.i11.2395

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  45 in total

1.  Telomerase activity analysis of esophageal carcinoma using microdissection-TRAP assay.

Authors:  Chun Li; Yingrui Liang; Mingyao Wu; Liyan Xu; Weijia Cai
Journal:  Chin Med J (Engl)       Date:  2002-09       Impact factor: 2.628

2.  Vaults and telomerase share a common subunit, TEP1.

Authors:  V A Kickhoefer; A G Stephen; L Harrington; M O Robinson; L H Rome
Journal:  J Biol Chem       Date:  1999-11-12       Impact factor: 5.157

3.  Telomerase activity in gastric cancer and its clinical implications.

Authors:  Wen-Hua Zhan; Jin-Ping Ma; Jun-Sheng Peng; Jing-Song Gao; Shi-Rong Cai; Jian-Ping Wang; Zhang-Qing Zheng; Lei Wang
Journal:  World J Gastroenterol       Date:  1999-08       Impact factor: 5.742

4.  Comparative gene mapping of the human and mouse TEP1 genes, which encode one protein component of telomerases.

Authors:  T Saito; Y Matsuda; T Suzuki; A Hayashi; X Yuan; M Saito; J Nakayama; T Hori; F Ishikawa
Journal:  Genomics       Date:  1997-11-15       Impact factor: 5.736

5.  hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization.

Authors:  M Meyerson; C M Counter; E N Eaton; L W Ellisen; P Steiner; S D Caddle; L Ziaugra; R L Beijersbergen; M J Davidoff; Q Liu; S Bacchetti; D A Haber; R A Weinberg
Journal:  Cell       Date:  1997-08-22       Impact factor: 41.582

6.  Senescence mutants of Saccharomyces cerevisiae with a defect in telomere replication identify three additional EST genes.

Authors:  T S Lendvay; D K Morris; J Sah; B Balasubramanian; V Lundblad
Journal:  Genetics       Date:  1996-12       Impact factor: 4.562

7.  Reverse transcriptase motifs in the catalytic subunit of telomerase.

Authors:  J Lingner; T R Hughes; A Shevchenko; M Mann; V Lundblad; T R Cech
Journal:  Science       Date:  1997-04-25       Impact factor: 47.728

8.  Telomerase activity: a prevalent marker of malignant human prostate tissue.

Authors:  H J Sommerfeld; A K Meeker; M A Piatyszek; G S Bova; J W Shay; D S Coffey
Journal:  Cancer Res       Date:  1996-01-01       Impact factor: 12.701

9.  Telomerase activity in human bladder cancer.

Authors:  Y Lin; H Miyamoto; K Fujinami; H Uemura; M Hosaka; Y Iwasaki; Y Kubota
Journal:  Clin Cancer Res       Date:  1996-06       Impact factor: 12.531

10.  Telomere length, telomerase activity and telomerase RNA expression in human esophageal cancer cells: correlation with cell proliferation, differentiation and chemosensitivity to anticancer drugs.

Authors:  A Asai; Y Kiyozuka; R Yoshida; T Fujii; K Hioki; A Tsubura
Journal:  Anticancer Res       Date:  1998 May-Jun       Impact factor: 2.480

View more
  8 in total

1.  Inhibitory effects of antisense phosphorothioate oligodeoxynucleotides on pancreatic cancer cell Bxpc-3 telomerase activity and cell growth in vitro.

Authors:  Yun-Feng Wang; Ke-Jian Guo; Bei-Ting Huang; Yong Liu; Xiao-Yun Tang; Jian-Jun Zhang; Qiang Xia
Journal:  World J Gastroenterol       Date:  2006-07-07       Impact factor: 5.742

2.  Evidence of extra-telomeric effects of hTERT and its regulation involving a feedback loop.

Authors:  Serene R Lai; Amanda P Cunningham; Vu Q Huynh; Lucy G Andrews; Trygve O Tollefsbol
Journal:  Exp Cell Res       Date:  2006-10-25       Impact factor: 3.905

3.  Serum human telomerase reverse transcriptase: a novel biomarker for breast cancer diagnosis.

Authors:  Mahendar Porika; Radhika Tippani; Sekhar R Bollam; Sree Divya Panuganti; Christopher Thamidala; Sadanandam Abbagani
Journal:  Int J Clin Oncol       Date:  2011-04-28       Impact factor: 3.402

4.  Effects of short-term exposure to inhalable particulate matter on telomere length, telomerase expression, and telomerase methylation in steel workers.

Authors:  Laura Dioni; Mirjam Hoxha; Francesco Nordio; Matteo Bonzini; Letizia Tarantini; Benedetta Albetti; Alice Savarese; Joel Schwartz; Pier Alberto Bertazzi; Pietro Apostoli; Lifang Hou; Andrea Baccarelli
Journal:  Environ Health Perspect       Date:  2010-12-17       Impact factor: 9.031

Review 5.  Regulation of the Telomerase Reverse Transcriptase Subunit through Epigenetic Mechanisms.

Authors:  Kayla A Lewis; Trygve O Tollefsbol
Journal:  Front Genet       Date:  2016-05-09       Impact factor: 4.599

6.  Azidothymidine inhibits cell growth and telomerase activity and induces DNA damage in human esophageal cancer.

Authors:  Haoli Wang; Jianwen Zhou; Qiong He; Yu Dong; Yanhui Liu
Journal:  Mol Med Rep       Date:  2017-05-03       Impact factor: 2.952

Review 7.  None-endoscopic Screening for Esophageal Squamous Cell Carcinoma- A Review.

Authors:  Gholamreza Roshandel; Shahryar Semnani; Reza Malekzadeh
Journal:  Middle East J Dig Dis       Date:  2012-04

Review 8.  Targeting Telomeres and Telomerase: Studies in Aging and Disease Utilizing CRISPR/Cas9 Technology.

Authors:  Andrew C Brane; Trygve O Tollefsbol
Journal:  Cells       Date:  2019-02-21       Impact factor: 6.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.